HPV vaccine can prevent most anal cancers: study
A News & Events entry posted on October 28, 2011
WASHINGTON — A vaccine against the sexually transmitted disease HPV, which can cause cervical cancer in women, has also been shown to prevent most anal cancers in gay men, an international study said Wednesday.
Men who were vaccinated against human papillomavirus developed 75 percent fewer anal lesions that lead to cancer than their counterparts who were given a placebo, said the study in The New England Journal of Medicine.
The findings were released one day after a US advisory panel urged the Centers for Disease Control and Prevention to recommend routine vaccinations for boys age 11-12 against HPV.
The disease infects at least half of all sexually active adults and can cause genital warts, but often people with HPV show no symptoms at all.
If caught early, the lesions caused by four particularly virulent strains of the virus can often be removed, preventing cancer from forming. But experts say vaccinating against it before people start to have sex is crucial.
There are nearly 6,000 cases of anal cancer diagnosed annually in the United States, and close to 800 deaths, according to US government health statistics.
"What this trial showed is that those cancers and deaths could be prevented," said lead author Joel Palefsky, a professor at University of California San Francisco and director of UCSF’s Anal Neoplasia Clinic.
News Archive
- April 2012
- March 2012
- February 2012
- November 2011
- October 2011
- August 2011
- May 2011
- April 2011
- February 2011
- December 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- October 2009
- September 2009
- August 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- June 2008
